Using Hippophae rhamnoides leaf extract in the treatment of chicken pox in children
Keywords:chicken pox, children, Hippophae rhamnoides extract
AbstractBackground. In Ukraine, about 150 thousand children suffer from chicken pox every year. Symptomatic and supportive treatment is indicated for all forms of chicken pox. The purpose of the study was to evaluate the efficacy and tolerability of Hippophae rhamnoides (Erebra) extract in the comprehensive treatment of chicken pox in children. Materials and methods. Research design: prospective, open-label, controlled. The study involved children who underwent inpatient treatment with a diagnosis of chicken pox during 2017–2018. Patients in the main group received Hippophae rhamnoides extract in the combined treatment of chicken pox, standard symptomatic therapy was prescribed to control patients. Results. Sixty four children were examined, the main group consisted of 34 patients, control group — 30 individuals. On the background of therapy, a positive dynamics of clinical symptoms was observed in all patients. On day 5, fever was more frequently detected in controls than in the main group (50.0 vs 23.5 %, p < 0.05 according to the χ2 criterion). Disorders of the general state on day 3 of observation were noted in 55.8 % of children in the main group and in 86.7 % of controls (p < 0.05 according to χ2 criterion). Conclusions. The use of Hippophae rhamnoides extract in comprehensive therapy of children with chicken pox accelerates the normalization of clinical symptoms. The Hippophae rhamnoides extract has a high safety profile and is well tolerated.
National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Chickenpox (Varicella). Available from: https://www.cdc.gov/chickenpox/index.html. Accessed: July 1, 2016.
RxList. Valtrex (Valacyclovir Hydrochloride): Side Effects, Interactions, Warning, Dosage and Uses. Available from: https://www.rxlist.com/valtrex-drug.htm#description. Accessed: April 16, 2018.
Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008 Feb;65(2):203-9. doi: 10.1111/j.1365-2125.2007.02997.x.
Erebra: instructions for medical use of the drug. Compendium Drugs. 2017. Available from: https://compendium.com.ua/dec/263453/. Accessed: April 16, 2018.
Suomela JP, Ahotupa M, Yang B, Vasankari T, Kallio H. Absorption of flavonols derived from sea buckthorn (Hippophaë rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans. J Agric Food Chem. 2006 Sep 20;54(19):7364-9. doi: 10.1021/jf061889r.
Jain M, Ganju L, Katiyal A, et al. Effect of Hippophae rhamnoides leaf extract against Dengue virus infection in human blood-derived macrophages. Phytomedicine. 2008 Oct;15(10):793-9. doi: 10.1016/j.phymed.2008.04.017.
Geetha S, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides) - an in vitro study. J Ethnopharmacol. 2002 Mar;79(3):373-8.
Larmo P, Alin J, Salminen E, Kallio H, Tahvonen R. Effects of sea buckthorn berries on infections and inflammation: a double-blind, randomized, placebo-controlled trial. Eur J Clin Nutr. 2008 Sep;62(9):1123-30. doi: 10.1038/sj.ejcn.1602831.
Enkhtaivan G, Maria JK, Pandurangan M, Hur J, Leutou A, Kim D. Extreme effects of Seabuckthorn extracts on influenza viruses and human cancer cells and correlation between flavonol glycosides and biological activities of extracts. Saudi Journal of Biological Sciences. 2017;24(7):1646-1656. doi: 10.1016/j.sjbs.2016.01.004.
Shipulina LD, Tolkachev ON, Krepkova LV, Bortnikova VV, Shkarenkov AA. Anti-viral, anti-microbial and toxicological studies on Seabuckthorn (Hippophae rhamnoides). In: Singh V, editor. Seabuckthorn (Hippophae L.): A Multipurpose Wonder Plant, Volume 2: Biochemistry and pharmacology. New Delhi, India: Indus Publishing Company; 2003. 471-483 pp.
Kwon EY, Lee J, Kim YJ, et al. Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity. Nutrients. 2017 Jun 2;9(6). pii: E569. doi: 10.3390/nu9060569.
Padwad Y, Ganju L, Jain M, et al. Effect of leaf extract of Seabuckthorn on lipopolysaccharide induced inflammatory response in murine macrophages. Int Immunopharmacol. 2006 Jan;6(1):46-52. doi: 10.1016/j.intimp.2005.07.015.
Tanwar H, Shweta, Singh D, Singh SB, Ganju L. Anti-inflammatory activity of the functional groups present in Hippophae rhamnoides (Seabuckthorn) leaf extract. Inflammopharmacology. 2018 Feb;26(1):291-301. doi: 10.1007/s10787-017-0345-0.
Jayashankar B1, Mishra KP, Kumar MS, et al. A supercritical CO₂ extract from seabuckthorn leaves inhibits pro-inflammatory mediators via inhibition of mitogen activated protein kinase p38 and transcription factor nuclear factor-κB. Int Immunopharmacol. 2012 Aug;13(4):461-7. doi: 10.1016/j.intimp.2012.05.011.
Jayashankar B1, Singh D1, Tanwar H, et al. Augmentation of humoral and cellular immunity in response to Tetanus and Diphtheria toxoids by supercritical carbon dioxide extracts of Hippophae rhamnoides L. leaves. Int Immunopharmacol. 2017 Mar;44:123-136. doi: 10.1016/j.intimp.2017.01.012.
Wani TA, Wani SM, Ahmad M, et al. Bioactive profile, health benefits and safety evaluation of sea buckthorn (Hippophae rhamnoides L.): A review. ," Cogent Food and Agriculture. 2016;2(1):1128519. doi: 10.1080/23311932.2015.1128519.
Copyright (c) 2018 ACTUAL INFECTOLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.